08:00 , Jan 19, 2015 |  BC Week In Review  |  Clinical News

Alere Determine HIV-1/2 Ag/Ab Combo test regulatory update

FDA granted a CLIA waiver to Alere Determine HIV-1/2 Ag/Ab Combo test from Alere as an aid in diagnosing HIV-1 and HIV-2 infection. The point-of-care test was previously marketed in the U.S. as a CLIA...
08:00 , Nov 4, 2013 |  BC Week In Review  |  Company News

Alere sales and marketing update

Alere launched its Alere Determine HIV-1/2 Ag/Ab Combo test in the U.S. as an aid in the diagnosis of HIV-1 and HIV-2 infection. FDA approved the test in August, at which time the agency said...
07:00 , Aug 19, 2013 |  BC Week In Review  |  Clinical News

Alere Determine HIV-1/2 Ag/Ab Combo test regulatory update

FDA approved a PMA from Alere for Alere Determine HIV-1/2 Ag/Ab Combo test as an aid in the diagnosis of HIV-1 and HIV-2 infection. The agency said Alere Determine is the first test that simultaneously...